With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

The next four years could be pivotal, with the potential to reshape the economy. Read why NSC and BCC stocks offer unique ...

Survey finds tariffs, tax cuts and immigration policy could weigh on price outlook for next two years.

Buffett -- as well as his late great partner Charlie Munger -- would recommend avoiding leverage at all costs in your ...

JPMorgan Chase stands head-and-shoulders above the rest of this group of largest U.S. banks by ROAA, while Morgan Stanley runs a pretty close second when its performance is measured by ROTCE. And with ...

The S&P 500's 2.9% climb this week left it up 2% in January through Friday, according to FactSet data. The Invesco S&P 500 Equal Weight ETF RSP staged a larger 3.9% rally this week, for a year-to-date ...

JPMorgan posts record profits, Lululemon raises guidance, Cogeco kickstarts three-year plan, and UnitedHealth beats ...

Another engine of value creation for Wall Street that has been slow in recent years is the IPO market — which is also set to ...

Wall Street’s so-called fear gauge has dropped this week, as the U.S. stock market appeared relieved that Treasury yields retreated from their recent climb. The Cboe Volatility Index was down 3.5% on ...

Shares of SLB advanced after the oilfield services giant announced a $2.3 billion stock buyback, bumped dividend payouts ...

Citi—which anticipates five rate cuts in 2025—has a downbeat forecast for a meager 0.7 percent growth. Bank of America is forecasting an above-consensus 2.4 percent growth for the year, hence their ...

Emboldened by a friendlier incoming Trump administration and their success last year in weakening draft capital hikes, big ...